Doximity, Inc. $DOCS Shares Sold by Empowered Funds LLC

Empowered Funds LLC lowered its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 7.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,743 shares of the company’s stock after selling 9,561 shares during the period. Empowered Funds LLC’s holdings in Doximity were worth $6,977,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Nomura Asset Management Co. Ltd. bought a new stake in shares of Doximity during the second quarter valued at about $442,000. Alberta Investment Management Corp bought a new position in Doximity in the 2nd quarter valued at about $1,454,000. Intech Investment Management LLC bought a new position in Doximity in the 2nd quarter valued at about $7,679,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Doximity by 7.5% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 34,301 shares of the company’s stock valued at $2,104,000 after buying an additional 2,389 shares during the period. Finally, Police & Firemen s Retirement System of New Jersey raised its position in shares of Doximity by 10.7% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 49,917 shares of the company’s stock worth $3,062,000 after buying an additional 4,823 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Down 3.4%

DOCS stock opened at $46.38 on Friday. Doximity, Inc. has a one year low of $46.04 and a one year high of $85.21. The firm has a 50-day moving average of $65.78 and a two-hundred day moving average of $62.17. The firm has a market capitalization of $8.73 billion, a PE ratio of 46.38, a P/E/G ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. Doximity’s revenue for the quarter was up 23.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.30 EPS. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, equities research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.

Insider Activity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the transaction, the director directly owned 19,839 shares of the company’s stock, valued at approximately $1,318,103.16. The trade was a 9.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares of the company’s stock, valued at approximately $241,575. This represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 32,000 shares of company stock worth $2,339,580 over the last quarter. Corporate insiders own 31.30% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on DOCS. Bank of America upgraded shares of Doximity from a “neutral” rating to a “buy” rating and increased their price objective for the company from $75.00 to $82.00 in a report on Monday, October 27th. Wells Fargo & Company increased their price target on Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research note on Monday, August 4th. KeyCorp boosted their price objective on Doximity from $75.00 to $80.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. The Goldman Sachs Group set a $64.00 price objective on Doximity and gave the company a “sell” rating in a report on Wednesday, October 1st. Finally, Canaccord Genuity Group lowered their target price on Doximity from $67.00 to $58.00 and set a “hold” rating on the stock in a report on Monday, November 10th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $68.78.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.